Laddar...
Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis
The contribution of Th17 cells to the development of colitis is well described. The effector cytokines IL-17A and IL-17F have been proposed as potential therapeutic targets for the treatment of patients with inflammatory bowel disease. In a proof-of-concept study for the treatment of patients with C...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3857957/ https://ncbi.nlm.nih.gov/pubmed/23998727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.13.87 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|